Recall events
/
Event 86442
Event summary
Timeline bucket September 16, 2020
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Calvin Scott & Company, Inc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
3 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 3
Diethylpropion, 25 mg tablets, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-1475-01
D-0009-2021
Recall number D-0009-2021
Initiated September 16, 2020
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Code information Lot #: CS19311, CS19337, Exp 12/20; CS20018B, CS20019, CS20037, CS20075, CS20076, CS20112, CS20169, Exp 8/21; CS20168, Exp 12/21; CS20199, Exp 5/22; CS20243, Exp 7/22
Distribution pattern Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12817]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 3
Diethylpropion, 75 mg tablets, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-1477-01
D-0010-2021
Recall number D-0010-2021
Initiated September 16, 2020
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Code information Lot #: CS19192, CS19226, CS19263, Exp 10/20; CS19300, Exp 7/21; CS19338, Exp 8/21; CS20034, Exp 10/21; CS20077, Exp 1/22, CS20165, CS20241, Exp 4/22
Distribution pattern Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12229]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 3
Phentermine, 30 mg capsules, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-0597-10
D-0011-2021
Recall number D-0011-2021
Initiated September 16, 2020
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Code information Lot #: CS19309, CS20098, Exp 12/21
Distribution pattern Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12081]
FDA event record
· Exact recall-number query on openFDA